Evidence map›Paper›PMID 34766590›Full record

Observational studyMedicine2021

APOL1 renal risk variants are associated with obesity and body composition in African ancestry adults: An observational genotype-phenotype association study.

Girish N Nadkarni, Kezhen Fei, Genevieve Galarneau, Yan Gao, James G Wilson, Richard Cooper, Ebony B Madden, Joshua C Denny, Lynne D Richardson, Martin Pollak and 2 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Apolipoproteins L involvement in immunity.Journal of human immunity · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. The metabolic effects of APOL1 in humans.Pflugers Archiv : European journal of physiology · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Girish N NadkarniDepartment of Medicine, The Charles Bronfman Institute for Personalized Medicine.ORCID 0000-0001-6319-4314
Kezhen FeiDepartment of Population Health Science and Policy, The Institute for Health Equity Research.
Genevieve GalarneauDepartment of Genetics and Genomic Sciences, Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Yan GaoDepartment of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS.
James G WilsonDepartment of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS.
Richard CooperDepartment of Public Health Sciences, Loyola University, Chicago, IL.
Ebony B MaddenDivision of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
Joshua C DennyDepartments of Biomedical Informatics and Medicine, Vanderbilt University School of Medicine, Nashville, TN.
Lynne D RichardsonDepartment of Emergency Medicine, Department of Population Health Science and Policy, The Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY.
Martin PollakDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess School of Medicine, Boston, MA.
Ruth J F LoosDepartment of Environmental Medicine & Public Health, The Charles Bronfman Institute for Personalized Medicine.
Carol R HorowitzDepartment of Population Health Science and Policy, Department of Medicine, The Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY.
Icahn School of Medicine at Mount Sinai · USUniversity of Mississippi Medical Center · USCenter for Health and Gender Equity · USLoyola University Chicago · USMount Sinai Health System · USNational Institutes of Health · USVanderbilt University · US

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Genomic Medicine Pilot For Hypertension And Kidney Disease In Primary CareU01HG007278 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOROWITZ, CAROL R · 2013 to 2018
$5.7M
Elucidating Genetic and Environmental Second Hits in Racial and Ethnic Minorities with APOL1 High-Risk GenotypesR01DK127139 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI NADKARNI, GIRISH NITIN · 2021 to 2025
$4.0M
NHGRI NIH HHS U01 HG007278NHGRI NIH HHS U01HG007278NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK111022NIDDK NIH HHS R01 DK127139
6 · The paper itself

Abstract

abstractWhile increased obesity prevalence among persons of African ancestry (AAs) compared to persons of European ancestry (EAs) is linked to social, environmental and behavioral factors, there are no gene variants that are common and significantly associated with obesity in AA populations. We sought to explore the association between ancestry specific renal risk variants in the apolipoprotein L1 (APOL1) gene with obesity related traits in AAs.We conducted a genotype-phenotype association study from 3 electronic medical record linked cohorts (BioMe Biobank, BioVU, nuGENE); randomized controlled trials (genetic testing to understand and address renal disease disparities) and prospective cohort study (Jackson Heart Study). We analyzed association of APOL1 renal risk variants with cross-sectional measures of obesity (average body mass index (BMI), and proportion of overweight and obesity) and with measures of body composition (in Jackson Heart Study).We had data on 11,930 self-reported AA adults. Across cohorts, mean age was from 42 to 49 years and percentage female from 58% to 75.3%. Individuals who have 2 APOL1 risk alleles (14% of AAs) have 30% higher obesity odds compared to others (recessive model adjusted odds ratio 1.30; 95% confidence interval 1.16-1.41; P = 2.75 × 10-6). An additive model better fit the association, in which each allele (47% of AAs) increases obesity odds by 1.13-fold (adjusted odds ratio 1.13; 95% confidence interval 1.07-1.19; P = 3.07 × 10-6) and increases BMI by 0.36 kg/m2 (∼1 kg, for 1.7 m height; P = 2 × 10-4). APOL1 alleles are not associated with refined body composition traits overall but are significantly associated with fat free mass index in women [0.30 kg/m2 increment per allele; P = .03].Thus, renal risk variants in the APOL1 gene, found in nearly half of AAs, are associated with BMI and obesity in an additive manner. These variants could, either on their own or interacting with environmental factors, explain a proportion of ethnic disparities in obesity.

Indexed as

Apolipoprotein L1Black or African AmericanAdultApolipoproteinsBody CompositionCross-Sectional StudiesFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansMiddle AgedObesityProspective StudiesRandomized Controlled Trials as TopicRisk FactorsAPOL1 protein, humanApolipoprotein L1Apolipoproteins

Identifiers

PMID34766590
PMCPMC8589256
OpenAlexW3213310847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.